Melior Discovery Inc - Company Review
Melior Discovery Inc - Company ReviewSummary
Melior Discovery Inc (Melior) is a contract research provider of phenotypic screening, in vivo pharmacology, drug abuse liability and seizure potential services. The company develops pharmacology platform to identify novel indications for pre-clinical and development stage drug candidates. Its expertise spans in therapeutic areas of inflammation, immunology, acute and chronic pain, dermatology, cardiovascular, gastrointestinal, psychiatric, neurological and neurodegenerative disorders. Melior's theraTRACE is an indications discovery platform used in in-vivo assays spanning multiple therapeutic areas. The company offers contract research services to pharmaceutical and biopharmaceutical companies that offer efficacy models, pharmacokinetic evaluations and bioanalytical testings. Melior is headquartered in Exton, Pennsylvania, the US.
This comprehensive company report of Melior Discovery Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.